Top Biotechnology companies in Sweden by Cash and Short-Term Investments

This ranking features the top 61 Biotechnology companies in Sweden ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 1.04 B, for July 08, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Sweden has the highest Cash and Short-Term Investments ?

The Biotechnology company in Sweden with the highest Cash and Short-Term Investments is Camurus AB (publ) (Stockholm Stock Exchange: CAMX.ST) at USD 256.74 M.

Which Biotechnology company in Sweden has the lowest Cash and Short-Term Investments ?

The Biotechnology company in Sweden with the lowest Cash and Short-Term Investments is BioInvent International AB (publ) (Stockholm Stock Exchange: BINV.ST) at None.

What are the top 10 Biotechnology companies in Sweden by Cash and Short-Term Investments ?

The top 10 Biotechnology companies in Sweden by Cash and Short-Term Investments are Camurus AB (publ), BioGaia AB (publ), Swedish Orphan Biovitrum AB (publ), Vitrolife AB (publ), Medicover AB (publ), Vimian Group AB (publ), BICO Group AB (publ), RaySearch Laboratories AB (publ), Biotage AB (publ) and Xvivo Perfusion AB (publ).

What are the bottom 10 Biotechnology companies in Sweden by Cash and Short-Term Investments ?

The bottom 10 Biotechnology companies in Sweden by Cash and Short-Term Investments are BioInvent International AB (publ), Bio-Works Technologies AB (publ), aXichem AB, AlzeCure Pharma AB (publ), Aptahem AB (publ), BioArctic AB (publ), AddLife AB (publ), Alzinova AB (publ), AcouSort AB (publ) and Cantargia AB (publ).